Come April, the National Association of Chain Drug Stores will put in place the first chairman in its 78-year history who has not come from the chain drug store industry. The NACDS chairman-in-waiting is Bob Loeffler. He is primarily a food retailer, having spent his retailing career with H.E.
The cost of Medicaid can be cut with benefit modification, more effective care management and more efficient drug purchasing.
Overlooked amid the cacophony of meetings planned, meetings scheduled, meetings held and meetings evaluated was a relatively quiet event late last month in Orlando, Fla. The meeting in question was the annual trade expo hosted by the Chain Drug Marketing Association.
Business executives don’t like uncertainty, but it’s a condition retail pharmacy operators and others involved in health care delivery will have to learn to live with for the foreseeable future.
or not — to happen in the chain drug retailing arena in 2011. • The National Association of Chain Drug Stores will finally begin to address some of the issues that have kept the organization from realizing its potential to fully dominate the retail trade association arena. As a
Aside from the necessary toiletry items, when most teenage girls go into the beauty isle of a store they are usually looking for nail polish.
It is widely recognized that the health care reform legislation enacted last year will have a profound effect on patients and providers. Less apparent is the impact the Affordable Care Act will have on employers and the people who work for them.
Jack Shewmaker’s sudden death in mid-November, the result of a massive heart attack at his home in Bentonville, Ark.
New evidence of Walmart’s ability to influence the development of the health care market emerged last month when UnitedHealthcare and its Prescription Solutions division teamed up with Kroger Co. and Safeway Inc.
in late 1959 to be precise — Eli Cohen, a 33-year-old entrepreneur with a retailing background that leaned heavily to apparel, opened a 500-foot “cut-rate” store on Broadway, between Duane and Reade streets, in Manhattan. The store mainly sold health and beauty aids, and its appeal, at a time when
The Republican tidal wave that swept through the nation’s political landscape earlier this month altered the balance of power in Washington and many state capitols and, in the process, created a greater degree of uncertainty for retail pharmacy operators.
In the mass retailing firmament, the retailer is king. For industry suppliers, a primary objective is getting close to the retail merchants who make the key decisions affecting their products. There’s no new news in the previous paragraph.
If a new survey of pharmaceutical executives whose companies account for more than 40% of the industry’s global revenue is any indication, an era characterized by a remarkable level of innovation may be drawing to a close.
This issue of Chain Drug Review contains our annual look at America’s 100 largest drug store markets and the shares of the various drug store retailers within those markets. As is usually the case, this year’s analysis offers some surprises.
The muted reaction from the consumer press to the announcement by Walmart and Humana Inc. that they are offering a low-cost, co-branded prescription drug plan (PDP) for Medicare beneficiaries was puzzling.
